Clinical course and management of fabry disease in three patients before the introduction of enzyme replacement therapy
<p><strong>Background:</strong> Fabry disease (FD) is an X-linked inherited disorder of glycosphingolipids metabolism. Clinical manifestations, the course and the cause of death are markedly different among the patients. Before the use of enzyme replacement therapy patients with FD...
Main Author: | Franc Verovnik |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2006-12-01
|
Series: | Zdravniški Vestnik |
Subjects: | |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2047 |
Similar Items
-
Fabry nephropathy before and after enzyme replacement therapy: important role of renal biopsy in patients with Fabry disease
by: Il Young Kim, et al.
Published: (2021-12-01) -
Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in Argentina
by: Gustavo Cabrera, et al.
Published: (2017-06-01) -
Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis
by: Taciane Alegra, et al.
Published: (2012-01-01) -
Enzyme Replacement Therapy in the Treatment of Fabry Disease
by: YU Che, et al.
Published: (2023-07-01) -
Pulmonary manifestations and the effectiveness of enzyme replacement therapy in Fabry Disease with the p. Arg227Ter (p.R227*) mutation
by: Päivi Pietilä‐Effati, et al.
Published: (2022-05-01)